Ñî¹óåú´«Ã½Ò•îl

Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Medicaid Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • Ñî¹óåú´«Ã½Ò•îl Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • High Postcancer Medical Bills
  • Federal Workers’ Health Data
  • Cyberattacks on Hospitals
  • ‘Cheap’ Insurance

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Thursday, Nov 13 2025

Full Issue

Research Roundup: The Latest Science, Discoveries, And Breakthroughs

Each week, Ñî¹óåú´«Ã½Ò•îl Health News compiles a selection of health policy studies and briefs.

The Epstein-Barr virus virus appears to be the trigger for the autoimmune disease lupus, according to groundbreaking research. (Devlin, 11/12)

Children with the skin condition atopic dermatitis (AD, or eczema) who are vaccinated against COVID-19 may experience fewer related infections and allergic complications, according to new research presented at the recent American College of Allergy, Asthma and Immunology Annual Scientific Meeting in Florida. (Van Beusekom, 11/12)

The results of multicenter trial indicate the antiparasitic drug ivermectin can be safely used in small children. ... Although ivermectin is widely used in mass drug administration campaigns for diseases such as onchocerciasis (river blindness), intestinal worms, and scabies, children under 15 kg (kilograms, or 33 pounds) have been excluded because of limited safety information. (Dall, 11/10)

Evidence of bidirectional associations between incident late-onset epilepsy and incident myocardial infarction (MI) emerged in a cohort of stroke-free middle-age and older adults. ... "Our findings highlight the interconnectedness of heart and vascular health with brain health in middle-aged and older adults," the authors wrote. (Lou, 11/5)

Regular use of pharmaceutical opioids was associated with elevated risk for cancers caused by opium, but not other cancers. (Sheikh et al, 11/11)

The BMJ has slapped an "expression of concern" on a much-publicized stem cell trial it published just 2 weeks ago. (Lou, 11/12)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Today, April 22
  • Tuesday, April 21
  • Monday, April 20
  • Friday, April 17
  • Thursday, April 16
  • Wednesday, April 15
More Morning Briefings
RSS Feeds
  • Ñî¹óåú´«Ã½Ò•îl
  • Special Reports
  • Morning Briefing
  • About Us
  • Republish Our Content
  • Contact Us

Follow Us

  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF